Suppr超能文献

尿毒症及慢性透析的神经学表现

Neurological manifestations of uraemia and chronic dialysis.

作者信息

Tzamaloukas A H, Agaba E I

机构信息

Department of Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico, USA.

出版信息

Niger J Med. 2004 Apr-Jun;13(2):98-105.

Abstract

BACKGROUND

The management of uraemic neurological manifestations is a major target of the treatment of the uraemic syndrome. Chronic dialysis is associated with novel neurological manifestations.

OBJECTIVE

To describe the clinical characteristics, pathogenesis and management of the main neurological syndromes encountered in uraemia and chronic dialysis.

METHODS

Review of the pertinent literature. Selected references, which have been critical in the understanding of the topic, were included in this review.

RESULTS

The main neurological manifestations of uraemia include encephalopathy, neuropathy that can affect cranial, peripheral and autonomic nerves, and proximal myopathy. Retention of uraemic toxins is the main putative cause of uraemic encephalopathy and neuropathy. Arrest or prevention of uraemic encephalopathy and neuropathy are main targets of the dialytic treatment and constitute major criteria of its adequacy. The main cause of uraemic myopathy is secondary hyperparathyroidism and parathyroidectomy is its main treatment. Chronic dialysis is associated with three main neurological syndromes, the disequilibrium syndrome, seen usually in the first few haemodialysis sessions and prevented by starting dialysis with a low dose and progressively increasing the dialysis dose in subsequent dialysis sessions, dialysis dementia, which results from aluminium overloading and is prevented by reducing exposure of the dialysis patients to aluminium, and nerve entrapment, particularly carpal tunnel syndrome, which is caused by beta2-microglobulin amyloidosis and may be prevented by the use of high-flux dialysers which provide relatively high clearance for beta2-microglobulin or by daily haemodialysis.

CONCLUSIONS

Specific neurological manifestations are part of the uraemic syndrome and may complicate chronic dialysis. The diagnosis of these manifestations, their differentiation from other neurological syndromes that can complicate the course of renal failure or dialysis, and their specific treatment require clinical acumen and represent a major challenge for physicians treating patients with chronic renal failure or undergoing chronic dialysis.

摘要

背景

尿毒症神经表现的管理是尿毒症综合征治疗的主要目标。慢性透析与新的神经表现相关。

目的

描述尿毒症和慢性透析中主要神经综合征的临床特征、发病机制及管理。

方法

回顾相关文献。本综述纳入了对理解该主题至关重要的选定参考文献。

结果

尿毒症的主要神经表现包括脑病、可影响颅神经、周围神经和自主神经的神经病变以及近端肌病。尿毒症毒素潴留是尿毒症脑病和神经病变的主要假定原因。阻止或预防尿毒症脑病和神经病变是透析治疗的主要目标,也是判断透析充分性的主要标准。尿毒症肌病的主要原因是继发性甲状旁腺功能亢进,甲状旁腺切除术是其主要治疗方法。慢性透析与三种主要神经综合征相关,即失衡综合征,通常见于最初几次血液透析过程中,可通过低剂量开始透析并在随后的透析过程中逐渐增加透析剂量来预防;透析性痴呆,由铝过载引起,可通过减少透析患者接触铝来预防;神经卡压,尤其是腕管综合征,由β2-微球蛋白淀粉样变性引起,可通过使用对β2-微球蛋白清除率相对较高的高通量透析器或每日血液透析来预防。

结论

特定的神经表现是尿毒症综合征的一部分,可能使慢性透析复杂化。这些表现的诊断、与可能使肾衰竭或透析过程复杂化的其他神经综合征的鉴别以及其特定治疗需要临床敏锐度,对治疗慢性肾衰竭患者或接受慢性透析的患者的医生而言是一项重大挑战。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验